Huaxin Cement Co Ltd A (600801)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 22.85 |
|---|---|
| 52-week range | 14.88 – 26.44 |
| Return, 1 month / 3 months | −3.9% / +5.5% |
| Return, 1 year / 3 years | +12.8% / +65.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 43.0% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 263.89M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Huaxin Cement is a Chinese cement producer based in Wuhan, in Hubei province. It makes cement, clinker and ready-mixed concrete, and also supplies aggregates and related building materials. Its customers are construction companies, infrastructure builders and property developers, served through plants and distribution networks in China and in several overseas markets. The company also runs environmental and waste-processing operations alongside its cement business.
The shares are listed on the Shanghai Stock Exchange in China under the code 600801, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Huaxin Cement Co Ltd A (600801) trades on the Shanghai Stock Exchange in China. It last closed at CNY 22.85 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 174 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.8% and over the last three months it rose 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -12.6% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.5% | ||
| 6-month return | -0.7% | ||
| 12-month return, skipping the last month | 17.4% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 43.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 263.89M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | −3.9% |
| 3 months | +5.5% |
| 6 months | −0.7% |
| 1 year | +12.8% |
| 3 years | +65.8% |
| 5 years | +35.9% |
Signals
| 50-day / 200-day average | 23.45 / 22.02 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jun 2023 | CNY 0.5100 |
| 14 Jun 2022 | CNY 1.0000 |
| 17 Jun 2021 | CNY 1.0800 |
| 8 Jul 2020 | CNY 1.2100 |
| 3 Jun 2019 | CNY 1.6100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.